Dr. David Hines, MD
What this data tells you about Dr. Hines
Dr. David Hines is an infectious disease specialist in Chicago, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Hines performed 74,514 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Hines received a total of $3,241 from 2 pharmaceutical and/or device companies across 15 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hines is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary — 2023
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, belatacept, 1 mg | 34,116 | $3 | $7 |
| Romosozumab injection (Evenity) for osteoporosis | 9,135 | $8 | $19 |
| Vedolizumab infusion (Entyvio) This procedure involves the administration of vedolizumab via injection. The dosage is measured in milligrams. |
9,000 | $17 | $48 |
| Denosumab injection (Prolia/Xgeva) | 6,720 | $18 | $48 |
| Inclisiran injection (Leqvio) for cholesterol | 4,828 | $9 | $21 |
| Dalbavancin injection, 5 mg An injection of the antibiotic dalbavancin, administered in a 5 mg dose. |
3,800 | $12 | $31 |
| Injection, tildrakizumab, 1 mg | 2,200 | $100 | $295 |
| Omalizumab injection (Xolair) for asthma/allergy | 1,995 | $30 | $77 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
1,160 | $26 | $210 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
438 | $95 | $200 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
278 | $52 | $224 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
161 | $11 | $35 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
159 | $56 | $180 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
104 | $134 | $480 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
87 | $105 | $403 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
72 | $63 | $170 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
70 | $17 | $150 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
65 | $7 | $126 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
47 | $8 | $25 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
33 | $12 | $66 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
26 | $20 | $95 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
20 | $87 | $245 |
Industry Payment Transparency
Open Payments through 2023 ↗Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2023)
All-time payments by company (2019-2023) ›
Associated products mentioned in payments ›
Geographic Context
1.8 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2023 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hines is a mixed practice specialist, with above-average Medicare volume (top 2% in IL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hines experienced with injection, belatacept, 1 mg?
Does Dr. Hines receive payments from pharmaceutical companies?
How do Dr. Hines's costs compare to other infectious diseases in Chicago?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology